Logo image of ABRA.CA

ABRASILVER RESOURCE CORP (ABRA.CA) Stock Fundamental Analysis

TSX-V:ABRA - TSX Venture Exchange - CA00379L3048 - Common Stock - Currency: CAD

2.94  +0.06 (+2.08%)

Fundamental Rating

2

ABRA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 799 industry peers in the Metals & Mining industry. ABRA has a great financial health rating, but its profitability evaluates not so good. ABRA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year ABRA has reported negative net income.
ABRA had a negative operating cash flow in the past year.
In the past 5 years ABRA always reported negative net income.
In the past 5 years ABRA always reported negative operating cash flow.
ABRA.CA Yearly Net Income VS EBIT VS OCF VS FCFABRA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -39.92%, ABRA is doing worse than 60.42% of the companies in the same industry.
With a Return On Equity value of -52.02%, ABRA perfoms like the industry average, outperforming 43.45% of the companies in the same industry.
Industry RankSector Rank
ROA -39.92%
ROE -52.02%
ROIC N/A
ROA(3y)-55.75%
ROA(5y)-39.02%
ROE(3y)-71.26%
ROE(5y)-49.14%
ROIC(3y)N/A
ROIC(5y)N/A
ABRA.CA Yearly ROA, ROE, ROICABRA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ABRA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABRA.CA Yearly Profit, Operating, Gross MarginsABRA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

7

2. Health

2.1 Basic Checks

Compared to 1 year ago, ABRA has more shares outstanding
ABRA has more shares outstanding than it did 5 years ago.
ABRA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ABRA.CA Yearly Shares OutstandingABRA.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M
ABRA.CA Yearly Total Debt VS Total AssetsABRA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

An Altman-Z score of 25.16 indicates that ABRA is not in any danger for bankruptcy at the moment.
ABRA's Altman-Z score of 25.16 is amongst the best of the industry. ABRA outperforms 83.15% of its industry peers.
ABRA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 25.16
ROIC/WACCN/A
WACCN/A
ABRA.CA Yearly LT Debt VS Equity VS FCFABRA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

2.3 Liquidity

ABRA has a Current Ratio of 1.62. This is a normal value and indicates that ABRA is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.62, ABRA perfoms like the industry average, outperforming 51.06% of the companies in the same industry.
A Quick Ratio of 1.62 indicates that ABRA should not have too much problems paying its short term obligations.
ABRA has a Quick ratio (1.62) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.62
ABRA.CA Yearly Current Assets VS Current LiabilitesABRA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

0

3. Growth

3.1 Past

ABRA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.96%.
EPS 1Y (TTM)-15.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-101.09%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
ABRA is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -18.92% yearly.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-18.92%

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
ABRA.CA Yearly Revenue VS EstimatesABRA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 100K 200K 300K
ABRA.CA Yearly EPS VS EstimatesABRA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2024 2025 2026 2027 0 0.1 -0.1

0

4. Valuation

4.1 Price/Earnings Ratio

ABRA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ABRA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ABRA.CA Price Earnings VS Forward Price EarningsABRA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABRA.CA Per share dataABRA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ABRA!.
Industry RankSector Rank
Dividend Yield N/A

ABRASILVER RESOURCE CORP

TSX-V:ABRA (4/25/2025, 7:00:00 PM)

2.94

+0.06 (+2.08%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-03 2025-04-03/amc
Earnings (Next)05-27 2025-05-27
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap448.50M
Analysts80
Price Target5.42 (84.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-123.19%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 14.97
P/tB 14.97
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0
BVpS0.2
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.92%
ROE -52.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-55.75%
ROA(5y)-39.02%
ROE(3y)-71.26%
ROE(5y)-49.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 37461%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.62
Altman-Z 25.16
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)8916.96%
Cap/Depr(5y)15265.7%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-101.09%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-18.92%
EBIT growth 1Y44.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-29.33%
EBIT Next 3Y19.17%
EBIT Next 5Y16.56%
FCF growth 1Y3.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.47%
OCF growth 3YN/A
OCF growth 5YN/A